A citation-based method for searching scientific literature

Anne Andermann, Ingeborg Blancquaert, Sylvie Beauchamp, Véronique Déry. Bull World Health Organ 2008
Times Cited: 431







List of co-cited articles
228 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Consolidated principles for screening based on a systematic review and consensus process.
Mark J Dobrow, Victoria Hagens, Roger Chafe, Terrence Sullivan, Linda Rabeneck. CMAJ 2018
63
12

[Principles and practice of mass screening for disease].
J M Wilson, Y G Jungner. Bol Oficina Sanit Panam 1968
426
7

Current status of newborn screening worldwide: 2015.
Bradford L Therrell, Carmencita David Padilla, J Gerard Loeber, Issam Kneisser, Amal Saadallah, Gustavo J C Borrajo, John Adams. Semin Perinatol 2015
213
6

Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies.
Josephine Johnston, John D Lantos, Aaron Goldenberg, Flavia Chen, Erik Parens, Barbara A Koenig. Hastings Cent Rep 2018
31
19

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
6

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
842
6

Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
Yin-Hsiu Chien, Shu-Chuan Chiang, Wen-Chin Weng, Ni-Chung Lee, Ching-Jie Lin, Wu-Shiun Hsieh, Wang-Tso Lee, Yuh-Jyh Jong, Tsang-Ming Ko, Wuh-Liang Hwu. J Pediatr 2017
60
8

Guiding policy decisions for genetic screening: developing a systematic and transparent approach.
A Andermann, I Blancquaert, S Beauchamp, I Costea. Public Health Genomics 2011
28
17

Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance.
Peter Burgard, Kathrin Rupp, Martin Lindner, Gisela Haege, Tessel Rigter, Stephanie S Weinreich, J Gerard Loeber, Domenica Taruscio, Luciano Vittozzi, Martina C Cornel,[...]. J Inherit Metab Dis 2012
64
7

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
5

Population screening in the age of genomic medicine.
Muin J Khoury, Linda L McCabe, Edward R B McCabe. N Engl J Med 2003
244
5

Genetic screening: a conceptual framework for programmes and policy-making.
Anne Andermann, Ingeborg Blancquaert, Véronique Déry. J Health Serv Res Policy 2010
14
35

Newborn Sequencing in Genomic Medicine and Public Health.
Jonathan S Berg, Pankaj B Agrawal, Donald B Bailey, Alan H Beggs, Steven E Brenner, Amy M Brower, Julie A Cakici, Ozge Ceyhan-Birsoy, Kee Chan, Flavia Chen,[...]. Pediatrics 2017
95
5

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
Jacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, Anne Connolly, Basil Darras, John Day, Richard Finkel, R Rodney Howell, Katherine Klinger, Nancy Kuntz,[...]. J Neuromuscul Dis 2018
88
4

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
4

Genomic newborn screening: public health policy considerations and recommendations.
Jan M Friedman, Martina C Cornel, Aaron J Goldenberg, Karla J Lister, Karine Sénécal, Danya F Vears. BMC Med Genomics 2017
41
9

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
193
4


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
4

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
Amit V Khera, Mark Chaffin, Krishna G Aragam, Mary E Haas, Carolina Roselli, Seung Hoan Choi, Pradeep Natarajan, Eric S Lander, Steven A Lubitz, Patrick T Ellinor,[...]. Nat Genet 2018
838
4

Responsible implementation of expanded carrier screening.
Lidewij Henneman, Pascal Borry, Davit Chokoshvili, Martina C Cornel, Carla G van El, Francesca Forzano, Alison Hall, Heidi C Howard, Sandra Janssens, Hülya Kayserili,[...]. Eur J Hum Genet 2016
127
4

Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes.
Heidi Carmen Howard, Bartha Maria Knoppers, Martina C Cornel, Ellen Wright Clayton, Karine Sénécal, Pascal Borry. Eur J Hum Genet 2015
47
8

Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
Eugenio Mercuri, Richard S Finkel, Francesco Muntoni, Brunhilde Wirth, Jacqueline Montes, Marion Main, Elena S Mazzone, Michael Vitale, Brian Snyder, Susana Quijano-Roy,[...]. Neuromuscul Disord 2018
248
3

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, W Dave Arnold, Louise R Rodino-Klapac, Thomas W Prior, Linda Lowes, Lindsay Alfano, Katherine Berry, Kathleen Church,[...]. N Engl J Med 2017
862
3

Pilot study of population-based newborn screening for spinal muscular atrophy in New York state.
Jennifer N Kraszewski, Denise M Kay, Colleen F Stevens, Carrie Koval, Bianca Haser, Veronica Ortiz, Anthony Albertorio, Lilian L Cohen, Ritu Jain, Sarah P Andrew,[...]. Genet Med 2018
56
5


Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.
Frederick E Dewey, Michael F Murray, John D Overton, Lukas Habegger, Joseph B Leader, Samantha N Fetterolf, Colm O'Dushlaine, Cristopher V Van Hout, Jeffrey Staples, Claudia Gonzaga-Jauregui,[...]. Science 2016
281
3

Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R Aberle, Amanda M Adams, Christine D Berg, William C Black, Jonathan D Clapp, Richard M Fagerstrom, Ilana F Gareen, Constantine Gatsonis, Pamela M Marcus, JoRean D Sicks. N Engl J Med 2011
3


Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
967
3

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.
Folefac Aminkeng, Amit P Bhavsar, Henk Visscher, Shahrad R Rassekh, Yuling Li, Jong W Lee, Liam R Brunham, Huib N Caron, Elvira C van Dalen, Leontien C Kremer,[...]. Nat Genet 2015
134
3

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.
H Visscher, C J D Ross, S R Rassekh, G S S Sandor, H N Caron, E C van Dalen, L C Kremer, H J van der Pal, P C Rogers, M J Rieder,[...]. Pediatr Blood Cancer 2013
103
3

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.
Folefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, Soomi Hwang, Michael J Rieder, Amit P Bhavsar, Anne Smith, Shubhayan Sanatani, Karen A Gelmon, Daniel Bernstein,[...]. Br J Clin Pharmacol 2016
107
3

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.
Henk Visscher, Colin J D Ross, S Rod Rassekh, Amina Barhdadi, Marie-Pierre Dubé, Hesham Al-Saloos, George S Sandor, Huib N Caron, Elvira C van Dalen, Leontien C Kremer,[...]. J Clin Oncol 2012
244
3

Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.
Alberto B Burlina, Giulia Polo, Leonardo Salviati, Giovanni Duro, Carmela Zizzo, Andrea Dardis, Bruno Bembi, Chiara Cazzorla, Laura Rubert, Roberta Zordan,[...]. J Inherit Metab Dis 2018
60
5

How is genetic testing evaluated? A systematic review of the literature.
Erica Pitini, Corrado De Vito, Carolina Marzuillo, Elvira D'Andrea, Annalisa Rosso, Antonio Federici, Emilio Di Maria, Paolo Villari. Eur J Hum Genet 2018
34
8

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
121
3

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Kandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Heather Rocha, Juliann M Savatt, Alyson E Evans, Loren M Butry,[...]. JAMA Netw Open 2018
79
3

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
Kelly A Metcalfe, Nida Mian, Melissa Enmore, Aletta Poll, Marcia Llacuachaqui, Sonia Nanda, Ping Sun, Kevin S Hughes, Steven A Narod. Breast Cancer Res Treat 2012
57
5

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
99
3

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
79
3

Epigenome-based cancer risk prediction: rationale, opportunities and challenges.
Martin Widschwendter, Allison Jones, Iona Evans, Daniel Reisel, Joakim Dillner, Karin Sundström, Ewout W Steyerberg, Yvonne Vergouwe, Odette Wegwarth, Felix G Rebitschek,[...]. Nat Rev Clin Oncol 2018
60
5

Policy Making in Newborn Screening Needs a Structured and Transparent Approach.
Marleen E Jansen, Karla J Lister, Henk J van Kranen, Martina C Cornel. Front Public Health 2017
10
30


Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.
Yvonne Bombard, Fiona A Miller, Robin Z Hayeems, Denise Avard, Bartha M Knoppers. Eur J Hum Genet 2010
36
8


Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening.
Royston Ong, Denise Howting, Alethea Rea, Hayley Christian, Pauline Charman, Caron Molster, Gianina Ravenscroft, Nigel George Laing. J Med Genet 2018
22
13

The harms of screening: a proposed taxonomy and application to lung cancer screening.
Russell P Harris, Stacey L Sheridan, Carmen L Lewis, Colleen Barclay, Maihan B Vu, Christine E Kistler, Carol E Golin, Jessica T DeFrank, Noel T Brewer. JAMA Intern Med 2014
137
3

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
87
3



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.